Intervention not reported
Number of serious adverse events ‐ pulmonary · treating infections in people with neutropenia or neutrophil dysfunction
It is very uncertain whether the intervention changes number of serious adverse events ‐ pulmonary (very low certainty).
1 finding from 1 review
Adverse events:incarceration Assessed by: incarceration between a 3‐ and 9‐month · adults with antisocial personality disorder
It is very uncertain whether impulsive lifestyle counselling + treatment‐as‐usual changes adverse events:incarceration Assessed by: incarceration between a 3‐… compared with treatment‐as‐usual alone (very low certainty).
1 finding from 1 review
Adverse events: death Assessed by: number of participant deaths between a 3‐ and 9‐month · adults with antisocial personality disorder
It is very uncertain whether impulsive lifestyle counselling + treatment‐as‐usual changes adverse events: death Assessed by: number of participant deaths… compared with treatment‐as‐usual alone (very low certainty).
1 finding from 1 review
Serious adverse events ‐ in total population randomised · critically ill patients
Early physical therapy showed no clear difference in serious adverse events ‐ in total population randomised compared with control (moderate certainty).
1 finding from 1 review
Serious adverse events, ‐ in total population randomised ‐ hypoglycaemia · critically ill patients
Intensive insulin therapy leads to higher serious adverse events, ‐ in total population randomised ‐… compared with conventional insulin therapy (high certainty).
1 finding from 1 review
Adverse events (infection, tendon or pulley injury, flare, cutaneous discomfort, fat necrosis) · patients with trigger finger
Open surgery showed no clear difference in adverse events (infection, tendon or pulley injury, flare, cutaneous… compared with steroid injection (low certainty).
1 finding from 1 review
Adverse events (infection, partial loss of movement, tendon or pulley injury, oedema or inflammation or hematoma, adherence) · patients with trigger finger
It is very uncertain whether percutaneous surgery changes adverse events (infection, partial loss of movement, tendon or… compared with open surgery (very low certainty).
1 finding from 1 review
Disease‐specific adverse events · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pneumonia and other serious adverse events · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients with cardiogenic pulmonary oedema
1 finding from 1 review
Adverse events · Adults with COPD
1 finding from 1 review
Adverse events · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse events · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse eventsd · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse eventsf · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Total adverse eventsg · drug‐resistant pulmonary tuberculosis
1 finding from 1 review
Serious adverse events · people with pulmonary hypertension
Exercise showed no clear difference in serious adverse events compared with control (moderate certainty).
1 finding from 1 review
Serious adverse events · drug‐resistant pulmonary tuberculosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · adults with drug‐sensitive pulmonary tuberculosis
Gatifloxacin‐containing 4‐month ATT regimens showed no clear difference in serious adverse events compared with standard 6‐month ATT regimens (moderate certainty).
1 finding from 1 review
Serious adverse events · adults with drug‐sensitive pulmonary tuberculosis
Moxifloxacin‐containing 4‐month ATT regimens showed no clear difference in serious adverse events compared with standard 6‐month ATT regimen (moderate certainty).
1 finding from 1 review